Literature DB >> 26831030

A Chronic Respiratory Pasteurella multocida Infection Is Well-Controlled by Long-Term Macrolide Therapy.

Masafumi Seki1, Tomomi Sakata, Masahiro Toyokawa, Isao Nishi, Kazunori Tomono.   

Abstract

A 57-year-old woman with severe bronchiectasis frequently received antibiotics, including penicillin, for acute exacerbations due to Pasteurella multocida. Although the bacteria showed a decrease in antibiotic susceptibility, her symptoms and X-ray findings became stable, and severe exacerbations were not observed for the last few years after a low-dose erythromycin treatment was started. The development of a respiratory infection with Pasteurella multocida is relatively uncommon, but it can be controlled by immunomodulation which is associated with long-term macrolide therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26831030     DOI: 10.2169/internalmedicine.55.4929

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan.

Authors:  Kazuki Takano; Daishi Shimada; Shota Kashiwagura; Yasuhiro Kamioka; Maya Hariu; Yuji Watanabe; Masafumi Seki
Journal:  Int Med Case Rep J       Date:  2021-07-12

2.  Mycobacterium abscessus Associated Peritonitis with CAPD Successfully Treated Using a Linezolid and Tedizolid Containing Regimen Suggested Immunomodulatory Effects.

Authors:  Masafumi Seki; Yasuhiro Kamioka; Kazuki Takano; Haruka Imai; Mai Shoji; Maya Hariu; Yukari Kabutoya; Yuji Watanabe
Journal:  Am J Case Rep       Date:  2020-06-29

3.  Pasteurella multocida pneumonia with hemoptysis: A case report.

Authors:  Yuka Aida; Takumi Kiwamoto; Kazutaka Fujita; Hiroaki Ishikawa; Haruna Kitazawa; Hiroko Watanabe; Nobuyuki Hizawa
Journal:  Respir Med Case Rep       Date:  2018-11-09

Review 4.  Infective Endocarditis by Pasteurella Species: A Systematic Review.

Authors:  Angeliki Alifragki; Argyro Kontogianni; Ioanna Protopapa; Stella Baliou; Petros Ioannou
Journal:  J Clin Med       Date:  2022-08-27       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.